Sponsors (14)
Want to know what is actually in this bill?
This is not an official government website.
Copyright © 2026 PLEJ LC. All rights reserved.
Adds a new subparagraph (KK) to subsection (s)(2) to include 'cancer diagnostic and laboratory tests' and adds a new subsection (nnn) defining 'cancer diagnostic and laboratory tests' and establishing frequency limitations.
Modifies payment/deductible provisions to add that the deductible shall not apply with respect to cancer diagnostic and laboratory tests as defined in section 1861(nnn).
Adds a new subparagraph (Q) to 1862(a)(1) to exclude from Medicare payment those cancer diagnostic and laboratory tests that are performed more frequently than covered under new section 1861(nnn).
Inserts a new paragraph into section 1905(a) to include 'cancer diagnostic and laboratory tests' (as defined in section 1861(nnn)) as medical assistance under Medicaid.
Amends section 2103(c) by adding a new paragraph (13) to require that, beginning January 1, 2027, CHIP child health assistance (and elected pregnancy-related assistance) include coverage of cancer diagnostic and laboratory tests as defined in section 1861(nnn).
Expands coverage of modern cancer diagnostic and lab tests across Medicare, Medicaid, and CHIP. It defines which genomic sequencing tests and their professional interpretation are covered, limits how often a person can receive them for the same cancer, and waives the Medicare deductible for these tests. States must ensure Medicaid and CHIP plans cover these tests starting January 1, 2027.
Creates a national education and awareness effort on genomic testing, led by the Department of Health and Human Services with the National Human Genome Research Institute. The program targets both physicians and the public, and encourages medical training programs and continuing education (including oncology) to teach how molecular diagnostics help detect tumor mutations at diagnosis and when cancer returns.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced February 26, 2025 by Doris Matsui · Last progress February 26, 2025
